Source: Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
B. Garfield, G. Keir, M. Anwar, M. Loebinger, R. Wilson, E. Renzoni, A. Wells, T. Maher (London, United Kingdom). Caspofungin to treat invasive pulmonary aspergillosis in sarcoidosis. Eur Respir J 2012; 40: Suppl. 56, 4366

Member's Comments

No comment yet.

Related content which might interest you: Invasive pulmonary aspergillosis in immunosuppressed patients Source: International Congress 2015 – How to approach and treat fungal and viral respiratory infections Year: 2015 Voriconazole treatment in CF patients with ABPA and/or invasive aspergillosis Source: Annual Congress 2010 - New aspects of cystic fibrosis Year: 2010 Comparison of clinical characteristics of invasive tracheobronchial aspergillosis with or without invasive pulmonary aspergillosis Source: International Congress 2019 – Complex respiratory infections in clinical practice Year: 2019 Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma Source: Eur Respir J 2011; 37: 865-872 Year: 2011 Diagnosis and treatment of invasive pulmonary aspergillosis in neutropenic patients Source: Eur Respir J 2001 Jan 01;19(4):743-755 Year: 2002 Surgery treatment of pulmonary aspergillosis Source: Annual Congress 2007 - Surgical management of thoracic infections and issues in respiratory physiology Year: 2007 Invasive pulmonary aspergillosis: What is the role of surgery in the voriconazole era? Source: Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections Year: 2012 Remarkably efficient inhaled antifungal monotherapy for invasive pulmonary aspergillosis Source: Eur Respir J 2012; 40: 271-273 Year: 2012 Treatment of chronic pulmonary aspergillosis by voriconazole compared with micafungin Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus Year: 2009 PET‘s importance in chronic pulmonary aspergillosis Source: Eur Respir J 2006; 28: Suppl. 50, 560s Year: 2006 A rare presentation of pulmonary aspergillosis: Bronchial stump aspergillosis Source: International Congress 2019 – CCC Respiratory infections Year: 2019 CT patterns of pulmonary sarcoidosis are associated with prognosis and complication of chronic pulmonary aspergillosis or non-tuberculous mycobacteria Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage Year: 2019 Invasive pulmonary aspergillosis in patients with severe COPD. Compative study between probable invasive infection and colonization Source: Annual Congress 2011 - Role of infection in exacerbations of COPD Year: 2011 Chronic pulmonary aspergillosis complicating sarcoidosis Source: Eur Respir J, 49 (6) 1602396; 10.1183/13993003.02396-2016 Year: 2017 Invasive pulmonary aspergillosis in immunocompetent patients acquired during renovation in a chest institute Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes Year: 2017 VATS-resection and lobectomy for invasive pulmonary aspergillosis in severely immunocompromised patients with hematologic diseases Source: Annual Congress 2010 - Actual challenges in thoracic surgery Year: 2010 Nontuberculous mycobacterial disease and Aspergillus-related lung disease in bronchiectasis Source: Eur Respir J 2006; 28: 352-357 Year: 2006 Treatment of chronic necrotizing pulmonary aspergillosis (CNPA) with micafungin (MCFG) Source: Eur Respir J 2005; 26: Suppl. 49, 410s Year: 2005 Therapy of pulmonary aspergillosis with newly developed azole-derivatives Source: Eur Respir J 2001; 18: Suppl. 33, 138s Year: 2001